NCT06437925

Brief Summary

Objectives: This study investigates the effects of daily consumption of probiotic ayran drink on gingival inflammation and the development of experimental gingivitis. Methods: A total of 54volunteer students were included in the present randomized, double-blind, placebo-controlled trial.The participants were divided randomly into two groups; The Control group consisted of 27 participants who consumed placebo ayran, while the 27 participants of the Test group consumed probiotic ayran (containing Lactobacillus acidophilus and Bifidobacterium bifidum) for 42 days twice a day.After 42 days, mechanical plaque control was interrupted for 5 days. The clinical parameters of gingivitis; Plaque index (PI), gingival index (GI), probing bleeding (BOP), probing depth (PPD) were recorded at baseline, day 42 (beginning of experimental gingivitis) and day 47 (the end of experimental gingivitis). At the same time points, gingival crevicular fluid had been collected for analysis of matrix metalloproteinase - 8 (MMP-8).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 31, 2024

Completed
Last Updated

May 31, 2024

Status Verified

May 1, 2024

Enrollment Period

3 months

First QC Date

May 22, 2024

Last Update Submit

May 29, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Plaque index

    PI was scored from 0 to 5 according to the color change obtained with the Mira-2 solution

    Plaque index will be recorded at baseline, at day 42 and 47

  • Gingival index

    GI is graded by visual assessment and mechanical stimulation of the gingival tissues, scoring the gingival condition according to the criteria

    Gingival index will be recorded at baseline, at day 42 and 47

  • Bleeding on probing

    The probing bleeding (BOP) index was determined by the presence/absence of bleeding ≈30 seconds after probing

    BOP will be recorded at baseline, at day 42 and 47

Study Arms (2)

Probiotic ayran drink

EXPERIMENTAL

The participants in this experimental group will use probiotic containing ayran for 42 days and then will be subjected to 5 days of experimental gingivitis.

Dietary Supplement: probiotic ayran drink

Placebo ayran drink

PLACEBO COMPARATOR

The participants in this control group will use control ayran without probiotics for 42 days and then will be subjected to 5 days of experimental gingivitis.

Dietary Supplement: Placebo ayran drink

Interventions

probiotic ayran drinkDIETARY_SUPPLEMENT

The test group has received probiotic ayran drink for 6 weeks

Probiotic ayran drink
Placebo ayran drinkDIETARY_SUPPLEMENT

The control group has received placebo ayran drink for 6 weeks

Placebo ayran drink

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Systemic healthy
  • Subjects with gingivitis defined as a BOP sites ≥ 10% and PD ≤ 3 mm
  • No radiographic bone loss
  • Non-smoking participants

You may not qualify if:

  • History of using antibiotics or anti-inflammatory drugs or probiotic preparations or food supplements in the last 6 months,
  • Undergoing orthodontic treatment,
  • Active carious lesions
  • Mouth breathing
  • History of allergy for milk or fermented milk products.
  • Taking medications affecting the gingiva and/or oral mucosa

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cukurova University Faculty of Dentistry

Adana, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Gingivitis

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Cenk Haytac, phd

    Professor Doctor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 22, 2024

First Posted

May 31, 2024

Study Start

January 15, 2023

Primary Completion

April 15, 2023

Study Completion

June 15, 2023

Last Updated

May 31, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

The data will be shared upon request

Shared Documents
STUDY PROTOCOL
Time Frame
The data is ready and can be shared for two years
Access Criteria
The data will be shared upon request

Locations